On October 10-11, representatives of Pure Clinical and MDR Regulator, Katarzyna Wesołowska and Małgorzata Pawlikowska, had the opportunity to participate in the 4th International Conference "Clinical Research is WE!" held in Warsaw. This event, bringing together key experts from the clinical research industry, provided an excellent platform for knowledge exchange, valuable insights, and networking with specialists from around the world.
GCP ICH E6 (R3) Updates: a foundation for the future of clinical research
One of the primary topics at this year’s conference was the revisions to the GCP ICH E6 (R3) guidelines, which are critical for the future of quality management and decentralization in clinical research. These new guidelines respond to the rapidly evolving needs of the industry and increasing demands for data safety and quality. Their introduction aims to help stakeholders adapt to the latest standards, creating a robust foundation for future research processes.
Exchange of experiences and collaboration
Katarzyna Wesołowska and Małgorzata Pawlikowska, representing Pure Clinical and MDR Regulator, were honored to participate in numerous discussion panels and workshops. Their presence at the conference underscores both companies’ commitment to advancing high-quality clinical research and supporting modern solutions in trial management. Participation in this event allowed them to expand their knowledge on the latest trends and technologies that have a direct impact on clinical research standards.
Decentralized clinical trials – the future of the industry?
A key topic discussed at the conference was the decentralization of clinical trials. This approach is gaining popularity due to the potential for conducting studies closer to the patient, which promotes greater participant engagement and shorter study timelines. Decentralization also enables better utilization of new technologies, such as telemedicine, which significantly enhances patient comfort. During the conference, much attention was devoted to both the benefits and challenges associated with implementing this model.
Pure Clinical and MDR Regulator’s commitment to innovation
Pure Clinical and MDR Regulator have long supported innovative approaches to clinical research, striving to raise standards and introduce modern solutions that benefit both researchers and patients. Participation in conferences like “WE! Are the Clinical Research” is a part of both companies’ strategy to stay updated on the latest trends and rapidly changing regulations in the industry.
Through their participation in this event, Pure Clinical and MDR Regulator representatives gained new experiences and inspiration that will undoubtedly contribute to the continued growth of their operations.
